Introduction
Charcot ' s pivotal observation of the pallor of the corticospinal tracts (CSTs) forms the diagnostic cornerstone of amyotrophic lateral sclerosis (ALS) as a neurodegenerative syndrome characterized by progressive loss of both upper motor neurons (UMNs) of the corticospinal tract (CST), and lower motor neurons (LMNs) arising from the brainstem and spinal anterior horns. ALS is clinically heterogeneous, and a signifi cant proportion of cases clinically shows relative selectivity for LMN or UMN involvement. There is also clinical, pathological and genetic overlap between ALS and some forms of frontotemporal dementia (FTD) (1).
A small proportion who manifest solely UMN signs clinically, typically of lower limb-onset, are termed primary lateral sclerosis (PLS). This syndrome was fi rst recognized by Erb (2) before clinicopathological papers defi ned the association with a consistently slower progression and survival typically callosum (CC), assumed to refl ect a secondary (Wallerian-type) loss of myelin (9).
Multi-component relaxation imaging separates MRI signal into contributions from sub-voxel anatomical water pools, broadly corresponding to intraand extra-cellular water (IE-water), which relaxes slowly, and water trapped between the myelin bilayers, which relaxes more quickly. The myelin water fraction (MWF) correlates strongly with gold standard histopathological measurements of myelin content (10,11), thus providing a non-invasive surrogate. Shifts in the T2 of the IE-water have been linked to changes in water content, and specifi cally infl ammation or oedema (12,13). Multi-component Driven Equilibrium Single Pulse Observation of T1 & T2 (mcDESPOT) (14), provides a wholebrain characterization of myelin-and IE-water changes. We explored mcDESPOT ' s sensitivity to differences in brain white matter microstructure to distinguish the pathological process in ALS and PLS.
Methods

Participants
Prevalent and incident cases of ALS and PLS seen in a large tertiary referral clinic, diagnosed by two experienced neurologists (KT, MRT) according to standard criteria, were offered participation as part of a larger multi-modal, six-monthly assessment, longitudinal Oxford Study for Biomarkers in Motor Neuron Disease ( ' BioMOx ' ). All patients were apparently sporadic apart from one individual with ALS and a dominant family history associated with a hexanucleotide repeat expansion in C9orf72. Healthy volunteers without signifi cant past medical history (spouses and friends of patients) were recruited for a single study only. All participants were capable of providing informed consent. The study was approved by the South Oxfordshire Research Ethics Committee.
Clinical assessment
All patients were examined at each visit (MRT). Disease duration was calculated in months from symptom onset to date of assessment. Disability was assessed using the revised ALS Functional Rating Score (ALSFRS-R, 0 -48, lower score refl ects greater disability). Progression rate was calculated as: (48 minus ALSFRS-R)/(disease duration). A sum score of pathological refl exes (0 -15) was used to stratify the clinical UMN burden (9,15).
Participants were assessed on the same day as MRI using the revised Addenbrookes Cognitive Examination (lower score refl ects poor cognitive performance (16)), except those few patients for whom signifi cant communication impairment precluded study ( n ϭ 3). Verbal fl uency sub-scores were analysed separately for the patients in addition to the total score. This included letter fl uency scores (as many words beginning with p in one minute) and category fl uency (as many animals beginning with any letter in one minute), with lower scores refl ecting worse performance. Those participants without signifi cant upper limb disability were also scored for the written Trail-Making Test (TMT) of executive function, in which the standard measure of Trail B minus Trail A time in seconds was used for scoring (higher score refl ects greater impairment of executive function).
MRI acquisition
Scans were performed at the Oxford Centre for Clinical Magnetic Resonance Research using a 3T Siemens Trio scanner (Siemens AG, Erlangen, Germany) with a 12-channel head coil. The mcDES-POT protocol consisted of a 14-min series of sagittal spoiled gradient recalled echo (SPGR) and balanced steady state free procession (bSSFP) acquisitions across a range of fl ip angles ( α ), as well as an inversion -recovery-prepared SPGR (IR-SPGR) scan for correction of fl ip angle inhomogeneity (17). A common fi eld of view of 22 ϫ 22 ϫ 18 cm and voxel size of 1.7 ϫ 1.7 ϫ 1.7 mm was used. Other scan parameters were: SPGR: TE • ϭ 2.5 ms; TR ϭ 5.6 ms; BW ϭ Ϯ 24 kHz; α ϭ [3, 4, 5, 6, 7, 9, 12 , 18] ° . bSSFP: TE • ϭ 2.2 ms; TR ϭ 4.4 ms; BW ϭ Ϯ 36 kHz; α ϭ [10, 13, 17, 20, 23, 30, 43, 60] ° ; all fl ip angles were acquired with phase-cycling patterns of ϕ ϭ 0 ° and 180 ° for correction of off-resonance effects (17). IR-SPGR: TE • ϭ 2.5 ms; TR ϭ 5.6 ms; BW ϭ Ϯ 24 kHz, TI ϭ 450 ms, α ϭ 5 ° , slice thickness ϭ 3.4 mm.
MRI analysis
mcDESPOT pre-processing. mcDESPOT datasets were linearly coregistered to account for subtle inter-scan motion using FLIRT, and non-brain parenchymal signal removed using an automated approach with BET (FMRIB Software Library, www.fmrib.ox.ac.uk/fsl). Voxelwise MWF and IEwater T2 maps were derived using published mcDESPOT processing (17).
White matter tract-based analysis. To spatially compare MWF values across subjects and groups, tractbased spatial statistics (TBSS) were applied (18), reducing bias due to inaccurate spatial registration by performing analysis along a skeletonized WM mask representing the mid-line of each WM pathway. TBSS does not make use of DTI fi bre orientation information, so may be directly applied to MWF maps with minor modifi cation (19).
Individual MWF images were non-linearly aligned to every other using standard TBSS registration methods, and the most representative MWF map was assigned as the target template. The target was then affi ne-aligned into MNI152 standard space, and individual MWF maps were transformed to this space by combining the non-linear transform to the target template with the affi ne transform to MNI152 space. The cross-subject mean MWF map was computed and used to generate a WM tract ' skeleton ' , thresholded at MWF Ͼ 0.1. Individual MWF images were projected onto the skeleton for statistical comparison. The identical transformation was applied to the IE-water T2 maps to create skeletonized IE-water T2 maps.
Group differences in MWF or IE-water T2, and relationships between these metrics and clinical measures were tested using Randomise along the TBSS skeleton. Statistical signifi cance was defi ned as p Ͻ 0.05, corrected for multiple comparisons by controlling family-wise error rate after ThresholdFree Cluster Enhancement (TFCE) (20). Global or ROI group differences were assessed using a MannWhitney test, and correlations using Spearman ' s rank order correlation coeffi cient.
Longitudinal analysis. Those patients with follow-up scans were included in a second TBSS analysis. Changes over time were assessed with a paired t -test using Randomise across the TBSS skeleton and also globally for the entire TBSS skeleton. Correlations with progression rate were also assessed using Spearman ' s rank order correlation coeffi cient.
Results
Participants
Thirty patients (23 ALS, seven PLS) and 12 control subjects underwent MRI. A total of 19 patients (15 ALS, four PLS) underwent a second scan (Table I) .
Cross-sectional MWF reductions
PLS compared to controls. Widespread, symmetrical regions of signifi cantly decreased MWF were found in PLS ( Figure 1A ). The mean reduction was 2.0% across the entire WM skeleton ( p Ͻ 0.05), and 4.4% for the area found to be signifi cant ( p Ͻ 0.0005).
ALS compared to controls. MWF was not significantly decreased compared to controls, with a mean only 0.2% lower than controls across the entire WM skeleton ( p ϭ 0.3). In an analysis of a subgroup of ALS patients with the highest clinical UMN score ( n ϭ 7, mean UMN score ϭ 14 (range 12 -15)), thus matching for the UMN characteristics of the PLS group, there was still no signifi cant decrease in MWF found anywhere in the WM skeleton between ALS and controls ( p ϭ 0.4). Similarly, no signifi cant reduction ( p ϭ 0.3) in MWF was found within a subgroup of ALS patients with the longest disease durations (approaching the disease duration characteristics of the PLS group; n ϭ 7, mean disease duration ϭ 99 Ϯ 28 months).
PLS compared to ALS. In direct comparison, MWF was signifi cantly lower for PLS patients than for ALS patients ( Figure 1B) , with a right hemisphere predominance. The average MWF reduction in PLS compared to ALS was 1.8% across the entire WM skeleton ( p Ͻ 0.05) and 4.3% for the area of most signifi cant reduction ( p Ͻ 0.0005).
Cross-sectional IE-water T2 increases
PLS compared to controls. There was a non-signifi cant trend (0.05 Ͻ p Ͻ 0.1) to increased IE-water T2 for PLS patients compared to healthy controls, seen within the corona radiata bilaterally ( Figure 1C) . The average increase across the WM skeleton was 1.0% ( p ϭ 0.06). Both need guarded interpretation given the small group size.
ALS compared to controls. IE-water T2 was significantly increased in ALS patients compared to healthy controls ( Figure 1D) , with an average increase across the WM skeleton of 0.6% ( p ϭ 0.1), but 3.8% for the area of most signifi cant increase ( p Ͻ 0.0001). The non-signifi cant trends of increase (0.05 Ͻ p Ͻ 0.1) lateralized to left corona radiata.
PLS compared to ALS. There were no signifi cant differences in IE-water T2 found between the two patient groups.
Correlations with physical disability and disease duration
No signifi cant correlations between MRI measures and UMN, ALSFRS-R, disease duration, or progression rate were found in either group of patients, nor for both groups combined (Table II) .
Correlations with cognitive dysfunction
The total ACE score was found to correlate with MWF (positively) and IE-water T2 (negatively) in the ALS group, but not the PLS group (Table II) . The correlations were found primarily in frontal regions (Figure 2 ). While the small PLS group size means these conclusions must be tentative, we noted that combining the patient groups reduced the signifi cance of these differences compared to controls.
The TMT B-A score correlated with MWF (negatively) and IE-water T2 (positively) when both patient groups were combined, but the IE-water T2 increases also for the ALS patient group in isolation (Table II) . The MWF correlations were spread throughout the white matter, but the IE-water T2 correlations were focused in frontal regions (Figure 3) . Letter fl uency was not correlated with either MRI parameter. However, category fl uency was correlated with MWF (positively) and IE-water T2 (negatively) for the ALS group, and more strongly with both patient groups combined. The MWF correlations were once again more widespread with the IE-water T2 correlations found primarily in frontal rather than temporal lobe projection tracts (Figure 4) .
With the implementation of rigorous Bonferroni correction for multiple measures (in addition to those measures inherent to the image analysis software), only the correlations between IE-water T2 and the total ACE score in ALS patients, and category fl uency in ALS patients and the combined patient group remained signifi cant.
Longitudinal MWF reductions
The average MWF across the entire TBSS skeleton was signifi cantly decreased at follow-up for the PLS patients (on average 1.4% lower, p ϭ 0.02), but not for the ALS patients (0.06% higher, p ϭ 0.9). However, no changes were signifi cant on a voxelwise basis for either group (data not shown). Change in MWF was not signifi cantly correlated with mean progression rate for PLS ( r ϭ Ϫ 0.80, p ϭ 0.20) nor ALS ( r ϭ Ϫ 0.21, p ϭ 0.5) patients, nor both groups combined ( r ϭ Ϫ 0.40, p ϭ 0.09).
Longitudinal IE-water T2 increases
The average IE-water T2 across the entire TBSS skeleton was signifi cantly increased at follow-up for the PLS patients (on average 1.6% higher, p ϭ 0.03), but not signifi cantly for the ALS patients (0.41% higher, p ϭ 0.3) (data not shown). Voxelwise, neither group alone showed a signifi cant increase, but combining both patient groups revealed signifi cant increases, though only on the left side of the brain (data not shown). Change in IE-water T2 was not signifi cantly correlated with mean progression rate for PLS ( r ϭ 0.80, p ϭ 0.20) nor ALS ( r ϭ 0.15, p ϭ 0.6) patients, nor both groups combined ( r ϭ 0.10, p ϭ 0.7).
Discussion
This exploratory in vivo cerebral myelin imaging study involved only a small number of PLS patients, and so the conclusions are necessarily tentative:
1. PLS patients were distinguished by widespread cerebral MWF reductions that did not appear simply driven by longer disease duration, level of disability or the larger UMN burden. 2. ALS, not PLS, patients had ' neuroinfl ammatory ' increased IE-water T2 in the cerebral deep white matter. 3. Reductions in global cognitive score and executive function (particularly category fl uency) Figure 1 . Reductions in MWF for PLS patients compared to healthy controls (A, signifi cant reductions in orange with trends in blue), and PLS patients compared to ALS patients (B, signifi cant reductions in red with trends in dark blue). Increases in IE-water T2 for PLS patients compared to healthy controls (C, non-signifi cant trends in light blue) and ALS patients compared to healthy controls (D, signifi cant increases in red-yellow with trends in green). All p -values corrected for multiple comparisons. Images displayed by radiological convention.
were linked to myelin changes with frontal lobe predominance in ALS.
Longitudinal changes in myelin imaging measures
were observed in the PLS rather than ALS group.
PLS as a distinct disorder
Clinical, genetic and neuropathological features of PLS support it being a distinct disorder, rather than an extreme of the spectrum of ALS (Table III) . The nosology of PLS emerged at the end of the 19th century (reviewed in (4)), followed in 1943 by a series of 21 cases contrasted clinically with ALS (21). The observation that humans have direct corticomotoneuronal connections to anterior horns has been postulated as the reason for UMN involvement more generally in ALS compared to LMN-only degenerations seen in lower-order animals (22). It is the striking atrophy of the primary motor cortex that has been most consistently observed as the distinguishing feature of PLS, visible on MRI (4,23), and matched by complete loss of Betz cells of layer V (4,24) to an extent rarely observed in ALS.
Post mortem insights
Post mortem studies in ALS, including those with no UMN signs, reveal consistent brain and cord pyramidal tract demyelination (25,26). There are few dedicated studies in PLS (Table IV) . Histology in three ALS patients with disease durations of 10, 17 and 20 years, respectively, revealed only mild loss of myelin staining in the cords of two (27), so that the more profound myelin changes seen in PLS might not simply be due to disease duration per se.
Previous MRI insights
Reductions in FA were noted in the CC and right subcortical CST in six PLS patients, in contrast to reduced FA in the superior frontal gyrus in the ALS group (28). Progression rate was linked to reduced FA in the sub-cortical white matter in the regions of the PMC in PLS, and to the CC and more caudal CST in ALS. In a larger study, the ' core ' signature between both patient groups and healthy controls was similar, involving the CSTs and central motor fi bres of the CC (29,30), and in a comparative study with hereditary spastic paraparesis (31). Degeneration of myelin was noted post mortem in the posterior limb of the internal capsule in a case of PLS (32), and reduced FA in this region has prognostic value in both ALS and PLS (33).
Insights into the neuroinfl ammatory signal
Shifts in IE-water T2, noted cross-sectionally in the ALS group, have been linked to infl ammation or oedema (12,13). Neuroinfl ammatory mechanisms have been implicated in the pathogenesis of ALS (34), with activated microglia throughout motor and extramotor cerebral regions (15). In DTI-based studies, the coincidence of reduction in FA and increased RD (the diffusion direction perpendicular to the neuronal tract) has been postulated to refl ect secondary Wallerian-type demyelination (35), rather than a primary immunological attack.
The contribution of oligodendroglial cells to ALS pathogenesis is thought to involve a wider axonal support role (36).
Cognitive impairment in PLS versus ALS
Signifi cant changes in myelin integrity were detected, predominantly frontal lobe regions, in relation to both global and executive measures of cognitive dysfunction in the ALS group, and in the patient groups combined, in keeping with the understanding of ALS and FTD as part of a clinicopathological spectrum (37). Myelin changes in the CC were strikingly anterior, probably refl ecting the projection of such fi bres to frontal regions (38), and raising the possibility of using regional CC involvement as a surrogate for extramotor pathology. Detailed including LMN-only cases (51). The present study did not fi nd longitudinal changes in myelin in the ALS group but, across the whole white matter skeleton, longitudinal decreases in MWF and increases in IE-water T2 were noted in the PLS group. Given the slower progression of disease in PLS, this was unexpected but may provide evidence for PLS as a more active pathological process than is clinically obvious, or refl ect the relative ' reserve ' of unaffected white matter compared to a decimated pathological landscape in ALS.
Limitations of the technique
The mcDESPOT sequence is currently limited to examining two water pools. Studies using techniques that allow fi tting of a T2 distribution can detect additional water pools, and long-T2 components have been demonstrated in multiple sclerosis (52). mcDESPOT also yields higher MWF values than are generally observed using multi-echo T2-relaxation, which could be the result of the two-pool model of mcDESPOT, magnetization transfer effects, or differences in modelling of exchange between pools (17,53).
Concluding remarks
Notwithstanding the need for a larger, prospective study using incident cases (ideally of shorter symptomatic duration), mcDESPOT offers novel potential to distinguish PLS from ALS by the degree and extent of myelin involvement. PLS may be a more active pathological process than its rate of clinical deterioration implies, and this study supports the view that it has a distinct pathogenesis.
cognitive studies in PLS are scarce, and though reported as similar dysfunction to ALS (39), it was to a lesser extent (40). In contrast to ALS, FTD is not frequently reported in the context of PLS beyond single case reports (41 -43). Comparative fl umazenil PET studies showed loss of GABA A receptor binding in frontal regions in the ALS compared to PLS group (44). PLS histopathology appears fi rmly based in the cerebral motor cortex, a region known to have strong connectivity with frontotemporal cortices (45). A blunted response of motor neurons to excitatory responses has been noted in PLS (46), which might relate to a wider theme of preserved inhibitory interneuronal function underlying differences in progression rate (47,48).
Longitudinal changes in cerebral white matter in PLS
Results of studies of longitudinal change in DTI measures in ALS have ranged from non-detectable (49) to very limited (50), to more widespread and
